Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Catalent, Inc. (CTLT)  
$56.53 0.16 (0.28%) as of 4:30 Tue 5/7


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 207,851,000
Market Cap: 11.75(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $31.86 - $59.82
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Catalent is a holding company. Through its subsidiaries, Co. has two operating and reporting segments: Biologics and Pharma and Consumer Health. The Biologics segment provides development and manufacturing for biologic proteins; cell, gene, and other nucleic acid therapies; plasmid DNA; induced pluripotent stem cells; and vaccines. The Pharma and Consumer Health segment comprises Co.'s capabilities for oral solids, softgel formulations, Zydis® fast-dissolve technologies, and gummy, soft chew, and lozenge dosage forms; formulation, development, and manufacturing platforms for oral, nasal, inhaled, and topical dose forms; and clinical trial development and supply services.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,000 1,000
Total Buy Value $0 $0 $49,980 $49,980
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 387 387 11,063 116,582
Total Sell Value $21,749 $21,749 $512,581 $11,151,362
Total People Sold 1 1 12 18
Total Sell Transactions 1 1 25 69
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 821
  Page 9 of 33  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Fasman Steven L EVP & Chief Admin Officer   •       –      –    2022-07-26 4 A $0.00 $0 D/D 2,788 56,509     -
   Fasman Steven L EVP & Chief Admin Officer   •       –      –    2022-07-26 4 S $106.90 $272,167 D/D (2,546) 53,721 55%     
   Castellano Thomas P SVP, Chief Financial Officer   •       –      –    2022-07-26 4 A $0.00 $0 D/D 2,323 17,374     -
   Castellano Thomas P SVP, Chief Financial Officer   •       –      –    2022-07-26 4 S $106.90 $37,094 D/D (347) 15,051 55%     
   Gennadios Aristippos Group Pres. Pharma & Consumer   •       –      –    2022-07-01 4 A $107.02 $2,000,097 D/D 18,689 80,187     -
   Arnold Jonathan SVP & Chief Commercial Ofcr   •       –      –    2022-07-01 4 A $107.02 $300,084 D/D 2,804 48,792     -
   Fasman Steven L SVP & General Counsel   •       –      –    2022-06-10 4 AS $106.77 $535,352 D/D (5,000) 56,178 -36%     
   Gargiulo Mario SVP Global Ops Large Molecule   •       –      –    2022-06-10 4 S $106.59 $12,578 D/D (118) 4,640 36%     
   Zippelius Peter Director   –       •      –    2022-02-06 4 S $102.65 $49,999,994 I/I (487,092) 4,330,462 2%     
   Hopson Ricky VP, Chief Accounting Officer   •       –      –    2022-01-31 4 AS $103.39 $240,382 D/D (2,325) 17,073 6%     
   Whitlow Ricci S President, CSS   •       –      –    2022-01-21 4 AS $102.37 $18,836 D/D (184) 2,923 2%     
   Flynn Karen Chief Commercial Officer   •       –      –    2022-01-10 4 AS $116.64 $288,334 D/D (2,472) 33,223 -16%     
   Fasman Steven L SVP & General Counsel   •       –      –    2022-01-03 4 A $0.00 $0 D/D 4,017 61,178     -
   Grippo Michael J SVP, Strategy & Corp. Dev.   •       –      –    2022-01-03 4 A $0.00 $0 D/D 4,017 16,519     -
   Pravda Ricardo SVP & Chief HR Officer   •       –      –    2022-01-03 4 A $0.00 $0 D/D 4,017 15,764     -
   Arnold Jonathan Pres. Oral & Specialty Deliv.   •       –      –    2022-01-03 4 A $0.00 $0 D/D 4,017 45,988     -
   Gennadios Aristippos President Softgel & Oral Tech   •       –      –    2022-01-03 4 A $0.00 $0 D/D 4,017 61,498     -
   Gunther Scott SVP, Quality & Reg. Affairs   •       –      –    2022-01-03 4 A $0.00 $0 D/D 4,017 22,079     -
   Lucier Gregory T Director   –       •      –    2021-11-23 4 S $126.98 $645,407 I/I (5,068) 0 14%     
   Arnold Jonathan Pres. Oral & Specialty Deliv.   •       –      –    2021-11-01 4 AS $140.02 $1,494,293 D/D (10,672) 41,971 -31%     
   Arnold Jonathan Pres. Oral & Specialty Deliv.   •       –      –    2021-11-01 4 OE $36.02 $338,421 D/D 7,559 52,643     -
   Gargiulo Mario SVP Global Ops Large MoleculeO   •       –      –    2021-10-28 3 IO $0.00 $0 D/D 0 4,758 -29%     
   Carletti Lorenzo SVP Global Ops Small MoleculeO   •       –      –    2021-10-28 3 IO $0.00 $0 D/D 0 3,580 -29%     
   Castellano Thomas P SVP, Chief Financial Officer   •       –      –    2021-10-20 4 AS $134.00 $309,138 D/D (2,307) 15,398 -23%     
   Arnold Jonathan Pres. Oral & Specialty Deliv.   •       –      –    2021-10-14 4 AS $129.41 $214,950 D/D (1,661) 45,084 -21%     
  821 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 33
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us